Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis
Public ClinicalTrials.gov record NCT00179478. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Controlled High-risk Avonex Multiple Sclerosis Prevention Study in Ongoing Neurologic Surveillance (CHAMPIONS10)
Study identification
- NCT ID
- NCT00179478
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Beth Israel Deaconess Medical Center
- Other
- Enrollment
- 155 participants
Conditions and interventions
Conditions
Interventions
- interferon beta 1a 30 ug IM once weekly Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2001
- Primary completion
- Feb 28, 2009
- Completion
- Feb 28, 2009
- Last update posted
- Sep 5, 2017
2001 – 2009
United States locations
- U.S. sites
- 20
- U.S. states
- 15
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| MS Treatment Center at Griffin Hospital | Derby | Connecticut | 06418 | — |
| Jaeb Center for Health Research | Tampa | Florida | 33647 | — |
| MS Center of Atlanta | Atlanta | Georgia | 30327 | — |
| Beta Research, Inc | Elk Grove | Illinois | 60007 | — |
| University of Iowa College of Medicine | Iowa City | Iowa | 52242 | — |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | — |
| Michigan State University | East Lansing | Michigan | 48824 | — |
| St. Louis University Health Sciences Center | St Louis | Missouri | 63110 | — |
| Jacobs Neurological Institute | Buffalo | New York | 14203 | — |
| University of Rochester | Rochester | New York | 14642 | — |
| Carolinas Medical Center - MS Center | Charlotte | North Carolina | 28207 | — |
| Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | — |
| The Ohio State University | Columbus | Ohio | 43210 | — |
| The Neurology Group | Norristown | Pennsylvania | 19401 | — |
| Univeristy of Pennsylvania Medical Center | Philadelphia | Pennsylvania | 19104 | — |
| Allegheny Neurological Associates | Pittsburgh | Pennsylvania | 15212 | — |
| Univeristy of Texas Houston Health Science Center | Houston | Texas | 77030 | — |
| Virginia Commonwealth University/Medical College of Virginia | Richmond | Virginia | 23219 | — |
| Neurological Associates, Inc. | Richmond | Virginia | 23230 | — |
| Marshfield Clinic | Marshfield | Wisconsin | 54449 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00179478, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 5, 2017 · Synced May 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00179478 live on ClinicalTrials.gov.